Company intelligence / Profile preview

Pie Medical Imaging

Maastricht, Limburg, Netherlands

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Pie Medical Imaging's solutions for cardiovascular image analysis, including the recently released CAAS Qardia 2.1 and CAAS MR Solutions 5.3.3, are commercially available and widely validated for clinical research and diagnosis. Their flagship vFFR technology is the subject of multicenter FASTIII clinical trials, with enrollment completed by June 2024. CAAS products are considered a gold standard for quantitative cardiac imaging analysis.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

Major imaging hardware and OEM companies (various, via integration/white-labeling)[4]

Beyond the preview

Go deeper on Pie Medical Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pie Medical Imaging.

Explore the full profile